These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36977990)

  • 1. Estimating individualized treatment effects from randomized controlled trials: a simulation study to compare risk-based approaches.
    Rekkas A; Rijnbeek PR; Kent DM; Steyerberg EW; van Klaveren D
    BMC Med Res Methodol; 2023 Mar; 23(1):74. PubMed ID: 36977990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Models with interactions overestimated heterogeneity of treatment effects and were prone to treatment mistargeting.
    van Klaveren D; Balan TA; Steyerberg EW; Kent DM
    J Clin Epidemiol; 2019 Oct; 114():72-83. PubMed ID: 31195109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives.
    Brookes ST; Whitley E; Peters TJ; Mulheran PA; Egger M; Davey Smith G
    Health Technol Assess; 2001; 5(33):1-56. PubMed ID: 11701102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance metrics for models designed to predict treatment effect.
    Maas CCHM; Kent DM; Hughes MC; Dekker R; Lingsma HF; van Klaveren D
    BMC Med Res Methodol; 2023 Jul; 23(1):165. PubMed ID: 37422647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment and implication of prognostic imbalance in randomized controlled trials with a binary outcome--a simulation study.
    Chu R; Walter SD; Guyatt G; Devereaux PJ; Walsh M; Thorlund K; Thabane L
    PLoS One; 2012; 7(5):e36677. PubMed ID: 22629322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating individualized treatment effects using an individual participant data meta-analysis.
    Bouvier F; Chaimani A; Peyrot E; Gueyffier F; Grenet G; Porcher R
    BMC Med Res Methodol; 2024 Mar; 24(1):74. PubMed ID: 38528447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simulation study on estimating biomarker-treatment interaction effects in randomized trials with prognostic variables.
    Haller B; Ulm K
    Trials; 2018 Feb; 19(1):128. PubMed ID: 29463271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline characteristics and statistical power in randomized controlled trials: selection, prognostic targeting, or covariate adjustment?
    Roozenbeek B; Maas AI; Lingsma HF; Butcher I; Lu J; Marmarou A; McHugh GS; Weir J; Murray GD; Steyerberg EW;
    Crit Care Med; 2009 Oct; 37(10):2683-90. PubMed ID: 19885979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A tutorial on individualized treatment effect prediction from randomized trials with a binary endpoint.
    Hoogland J; IntHout J; Belias M; Rovers MM; Riley RD; E Harrell F; Moons KGM; Debray TPA; Reitsma JB
    Stat Med; 2021 Nov; 40(26):5961-5981. PubMed ID: 34402094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of treatment with a continuous variable: simulation study of significance level for several methods of analysis.
    Royston P; Sauerbrei W
    Stat Med; 2013 Sep; 32(22):3788-803. PubMed ID: 23580422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple imputation for patient reported outcome measures in randomised controlled trials: advantages and disadvantages of imputing at the item, subscale or composite score level.
    Rombach I; Gray AM; Jenkinson C; Murray DW; Rivero-Arias O
    BMC Med Res Methodol; 2018 Aug; 18(1):87. PubMed ID: 30153796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgery for epilepsy.
    West S; Nevitt SJ; Cotton J; Gandhi S; Weston J; Sudan A; Ramirez R; Newton R
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD010541. PubMed ID: 31237346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammographic density, endocrine therapy and breast cancer risk: a prognostic and predictive biomarker review.
    Atakpa EC; Thorat MA; Cuzick J; Brentnall AR
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD013091. PubMed ID: 34697802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.